Ligand validation:8C88

NKP: (2R)-2-hydroxy-3-(phosphonooxy)propyl (9E)-octadec-9-enoate

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8C88_NKP_M_401	12%	85%	0.299	0.825	0.35	0.4	-	-	0	0	100%	1
8C88_NKP_H_301	8%	76%	0.325	0.805	0.32	0.61	-	1	0	0	100%	1
7OD5_NKP_M_401	58%	82%	0.151	0.929	0.33	0.47	-	-	2	0	100%	1
6Z1J_NKP_M_414	55%	84%	0.142	0.909	0.37	0.4	-	-	2	0	100%	1
7P0Q_NKP_M_401	47%	74%	0.172	0.912	0.38	0.61	-	1	2	0	100%	1
7Z8D_NKP_M_401	47%	78%	0.185	0.924	0.37	0.52	-	-	1	0	100%	1
7P17_NKP_M_401	36%	77%	0.188	0.882	0.35	0.57	-	-	0	0	100%	1
5DLW_NKP_A_904	60%	81%	0.143	0.93	0.37	0.45	-	-	9	0	100%	1
3NKP_NKP_A_1006	47%	39%	0.187	0.928	0.7	1.67	1	12	15	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.